图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukarGeneExpr.v19.i1.20
pages 47-60

Cancer Treatment-Related Bone Disease

Sue A. Brown
Department of Medicine, University of Virginia, Charlottesville, Virginia, USA
Theresa A. Guise
Division of Endocrinology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900

ABSTRACT

Bone health may be impaired in many patients being treated for cancer. Primary tumors that reside in or form metastases to bone can result in compromised skeletal integrity. It has also been increasingly recognized that patients undergoing therapies for treatment of cancer are at higher risk of bone loss. These include androgen-deprivation therapy for prostate cancer and aromatase inhibitor therapy for breast cancer, among others. Hypogonadism induced by many of these cancer treatments results in bone loss and increases the risk of osteoporosis and fractures. Progress has been made in identifying the role of oral and intravenous bisphosphonates to prevent bone loss in these patients. This review discusses bone loss associated with cancer treatments, with a focus on breast cancer, prostate cancer, and survivors of childhood malignancies.


Articles with similar content:

Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes
Journal of Environmental Pathology, Toxicology and Oncology, Vol.38, 2019, issue 2
Gaurav Gupta, Yogendra Singh, Kamal Dua, Rajiv Dahiya, Shiva Kumar Gubbiyappa, Dinesh Kumar Chellappan, Sushil Kumar Sah, Vijaya Paul Samuel
Physical Activity and Cancer: How May Protection Be Maximized?
Critical Reviews™ in Oncogenesis, Vol.8, 1997, issue 2-3
Roy J. Shephard, Robin Futcher
Side Effects of Chemotherapy in Musculoskeletal Oncology
Journal of Long-Term Effects of Medical Implants, Vol.20, 2010, issue 1
Panayiotis J. Papagelopoulos, Matteo Romantini, Andrea Angelini, Andreas F. Mavrogenis, Pietro Ruggieri
Perioperative Immunosuppression in Cancer Patients
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 2
Ricardo Vallejo, E. Daniela Hord, Steven A. Barna, Juan Santiago-Palma, Shihab Ahmed
Possible Role of Epidermal Growth Factor Receptors in the Therapy of Pancreatic Cancer
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.28, 2011, issue 4
R. S. R. Murthy, Suresh P. Vyas, Manish K. Gupta, Sahil Aggarwal, Swati Gupta